United States

ACADIA Pharmaceuticals Inc (ACAD.OQ)

ACAD.OQ on NASDAQ Stock Exchange Global Select Market

2:29pm EST
Change (% chg)

$0.46 (+1.59%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Select another date:

Tue, Nov 7 2017

BRIEF-Acadia Pharmaceuticals posts Q3 loss of $0.53 per share

* Acadia Pharmaceuticals reports third quarter 2017 financial results

BRIEF-Acadia Pharmaceuticals initiates phase III study of Pimavanserin

* Acadia Pharmaceuticals initiates phase III study of Pimavanserin in dementia-related psychosis

Big-name U.S. hedge funds shed healthcare stocks during the rally in second-quarter

NEW YORK Several big-name hedge fund investors trimmed their stakes in healthcare companies in the second quarter as the sector led the broad U.S. stock market higher, rallying amid a Republican effort to repeal and replace President Obama's signature healthcare law.

BRIEF-Acadia pharmaceuticals Q2 loss per share $0.55

* Acadia pharmaceuticals reports second quarter 2017 financial results

BRIEF-ACADIA Pharmaceuticals Q2 loss per share $0.55

* ACADIA Pharmaceuticals Inc - ‍expects that full-year NUPLAZID net sales for 2017 will be between $105 million and $115 million​

Select another date: